Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GLYC | GLYCOMIMETICS INC | $17.41M | $10.00k | -$36.35M | -$37.28M | -$0.58 | -86.67% | N/A | N/A | N/A | ||
| INTZ | INTRUSION INC | $9.32M | $5.43M | -$8.78M | -$10.87M | -$8.00 | -22.42% | -13.48% | N/A | N/A | ||
| ASLN | ASLAN PHARMACEUTICALS LTD | $7.47M | $12.00M | N/A | -$35.03M | -$1.75 | N/A | 31.95% | N/A | N/A | ||
| PPBT | PURPLE BIOTECH LTD | $9.92M | $0.00 | $22.27M | $19.88M | N/A | N/A | -100.00% | N/A | N/A | 2024-06-14 | |
| YTEN | YIELD10 BIOSCIENCE INC | $1.85M | $300.00k | -$12.53M | -$13.15M | -$32.85 | -16.90% | -13.51% | N/A | N/A | 2024-06-07 | |
| IQ | IQIYI INC | $4.96B | $4.43B | $1.48B | $267.43M | $0.28 | 8.05% | 4.45% | N/A | N/A | 2024-05-16 | |
| BPTH | BIO-PATH HOLDINGS INC | $3.71M | $0.00 | -$13.78M | -$13.96M | -$26.11 | N/A | N/A | N/A | N/A | ||
| CLNN | CLENE INC | $49.19M | $620.00k | -$41.91M | -$48.81M | -$0.46 | 12.73% | N/A | N/A | N/A | ||
| BIOL | BIOLASE INC | $5.14M | $48.83M | -$15.50M | -$38.26M | -$20.34 | 0.13% | 1.00% | N/A | N/A | ||
| BNED | BARNES & NOBLE EDUCATION INC | $10.10M | $1.55B | -$10.93M | -$82.10M | -$1.56 | 1.30% | -5.55% | N/A | N/A | ||
| LIFE | ATYR PHARMA INC | $132.16M | $588.00k | -$51.17M | -$53.93M | -$0.90 | -94.34% | N/A | N/A | N/A | 2024-06-05 | |
| LYRA | LYRA THERAPEUTICS INC | $21.70M | $1.68M | -$68.69M | -$68.88M | -$1.20 | 28.74% | N/A | N/A | N/A | 2024-06-13 | |
| DARE | DARE BIOSCIENCE INC | $36.39M | $2.82M | -$28.77M | -$28.87M | -$0.32 | -71.83% | N/A | N/A | N/A | ||
| APLM | APOLLOMICS INC | $30.70M | $0.00 | -$171.77M | -$172.60M | -$2.32 | N/A | N/A | N/A | N/A | ||
| APTO | APTOSE BIOSCIENCES INC | $19.25M | $0.00 | -$46.73M | -$47.17M | -$6.20 | N/A | N/A | N/A | N/A | ||
| CKPT | CHECKPOINT THERAPEUTICS INC | $60.07M | $68.00k | -$52.32M | -$52.32M | -$2.77 | -61.14% | -54.57% | N/A | N/A | ||
| GOSS | GOSSAMER BIO INC | $167.85M | $0.00 | -$155.21M | -$172.58M | -$1.00 | N/A | N/A | N/A | N/A | ||
| OCUP | OCUPHIRE PHARMA INC | $44.85M | $19.01M | -$11.28M | -$11.30M | -$0.48 | -54.30% | N/A | N/A | N/A | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $47.74M | $0.00 | -$40.07M | -$40.09M | -$1.59 | N/A | N/A | N/A | N/A | ||
| MVST | MICROVAST HOLDINGS INC | $131.95M | $341.00M | -$69.40M | -$101.58M | -$0.32 | 58.75% | N/A | N/A | N/A | 2024-06-04 | |
| EOSE | EOS ENERGY ENTERPRISES INC | $150.48M | $14.14M | -$148.45M | -$204.61M | -$1.40 | -39.71% | N/A | N/A | N/A | 2024-06-12 | |
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | $5.57M | $92.73k | -$8.35M | -$8.43M | -$2.31 | -53.29% | -68.21% | N/A | N/A | ||
| VIRX | VIRACTA THERAPEUTICS INC | $32.99M | $0.00 | -$43.83M | -$47.99M | -$1.23 | N/A | N/A | N/A | N/A | 2024-06-18 | |
| LUMO | LUMOS PHARMA INC | $18.18M | $1.53M | -$37.12M | -$37.13M | -$4.59 | -27.48% | -9.94% | N/A | N/A | 2024-05-31 | |
| SYBX | SYNLOGIC INC | $20.14M | $3.21M | -$68.01M | -$73.22M | -$7.96 | 188.74% | 5.06% | N/A | N/A | 2024-06-14 | |
| GOEV | CANOO INC | $181.70M | $886.00k | -$295.04M | -$323.44M | $2.10 | N/A | N/A | -57.40% | N/A | ||
| FEMY | FEMASYS INC | $29.55M | $1.05M | -$13.45M | -$14.90M | -$0.84 | -11.00% | N/A | N/A | N/A | ||
| MIST | MILESTONE PHARMACEUTICALS INC | $92.14M | $0.00 | -$51.60M | -$55.09M | -$1.25 | -100.00% | N/A | N/A | N/A | 2024-06-13 | |
| CLDI | CALIDI BIOTHERAPEUTICS INC | $11.92M | $0.00 | -$27.77M | -$29.98M | -$0.69 | N/A | N/A | N/A | N/A | 2024-05-29 | |
| IMRX | IMMUNEERING CORP | $46.56M | $0.00 | -$53.41M | -$54.18M | -$1.87 | -100.00% | N/A | N/A | N/A | ||
| GNLX | GENELUX CORP | $98.27M | $8.00k | -$25.42M | -$25.78M | -$0.97 | -99.93% | N/A | N/A | N/A | ||
| PRST | PRESTO AUTOMATION INC | $12.77M | $21.20M | -$48.24M | -$66.42M | -$1.31 | -30.61% | N/A | N/A | N/A | 2024-05-16 | |
| CARA | CARA THERAPEUTICS INC | $41.55M | $16.94M | -$117.75M | -$122.54M | -$2.26 | -60.83% | -1.04% | N/A | N/A | ||
| ACET | ADICET BIO INC | $115.04M | $0.00 | -$130.23M | -$139.79M | -$2.94 | N/A | -100.00% | N/A | N/A | 2024-06-05 | |
| GEVO | GEVO INC | $168.20M | $17.13M | -$46.43M | -$67.47M | -$0.29 | 242.39% | -11.20% | N/A | N/A | 2024-05-21 | |
| CVKD | CADRENAL THERAPEUTICS INC | $7.09M | $0.00 | -$4.84M | -$4.85M | -$0.31 | N/A | N/A | N/A | N/A | ||
| MRNS | MARINUS PHARMACEUTICALS INC | $73.06M | $28.29M | -$129.08M | -$145.34M | -$2.64 | 30.53% | N/A | N/A | N/A | 2024-05-22 | |
| AMPX | AMPRIUS TECHNOLOGIES INC | $124.70M | $10.71M | -$32.92M | -$37.56M | -$0.43 | 259.64% | N/A | N/A | N/A | ||
| AQMS | AQUA METALS INC | $45.40M | $25.00k | -$23.12M | -$25.08M | -$0.24 | 525.00% | -62.01% | N/A | N/A | ||
| NTBL | NOTABLE LABS LTD | $9.74M | $311.00k | -$11.19M | -$12.22M | -$5.05 | N/A | -13.47% | N/A | N/A | ||
| TPST | TEMPEST THERAPEUTICS INC | $75.09M | $0.00 | -$26.24M | -$29.76M | -$1.72 | N/A | N/A | N/A | N/A | 2024-06-13 | |
| INAB | IN8BIO INC | $49.86M | $0.00 | -$28.50M | -$31.04M | -$0.91 | N/A | N/A | N/A | N/A | ||
| DDC | DDC ENTERPRISE LTD | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| OTLK | OUTLOOK THERAPEUTICS INC | $173.90M | $0.00 | -$156.86M | -$159.13M | -$11.41 | N/A | -100.00% | N/A | N/A | 2024-05-16 | |
| FBIO | FORTRESS BIOTECH INC | $34.65M | $85.11M | -$31.95M | -$62.86M | -$6.10 | 32.48% | 25.39% | N/A | N/A | 2024-05-23 | |
| VOR | VOR BIOPHARMA INC | $118.77M | $0.00 | -$112.63M | -$120.23M | -$1.77 | N/A | N/A | N/A | N/A | 2024-05-23 | |
| TARA | PROTARA THERAPEUTICS INC | $76.39M | $0.00 | -$42.12M | -$42.47M | -$3.74 | N/A | N/A | N/A | N/A | ||
| IKNA | IKENA ONCOLOGY INC | $64.42M | $3.85M | -$67.40M | -$70.09M | -$1.57 | -78.07% | N/A | N/A | N/A | 2024-06-07 | |
| MBRX | MOLECULIN BIOTECH INC | $11.37M | $0.00 | -$26.70M | -$26.82M | -$13.04 | N/A | N/A | N/A | N/A | 2024-06-14 | |
| SGMT | SAGIMET BIOSCIENCES INC | $147.44M | $2.00M | -$27.78M | -$27.92M | -$38.69 | N/A | N/A | N/A | N/A | ||
| SPRB | SPRUCE BIOSCIENCES INC | $32.92M | $10.13M | -$47.11M | -$46.75M | -$1.13 | 415.63% | N/A | N/A | N/A | 2024-05-22 | |
| CMPS | COMPASS PATHWAYS PLC | $566.19M | $0.00 | -$122.97M | -$129.44M | -$2.35 | N/A | N/A | N/A | N/A | ||
| CMMB | CHEMOMAB THERAPEUTICS LTD | $12.40M | $0.00 | N/A | -$19.34M | -$1.56 | N/A | N/A | N/A | N/A | ||
| AGEN | AGENUS INC | $226.37M | $161.42M | -$114.19M | -$239.61M | -$12.64 | 69.94% | 7.01% | N/A | N/A | ||
| NOTV | INOTIV INC | $58.18M | $552.74M | $19.33M | -$71.29M | -$2.77 | -7.47% | 75.72% | N/A | N/A | ||
| PGEN | PRECIGEN INC | $363.48M | $5.44M | -$90.64M | -$96.91M | -$0.39 | -76.60% | -47.32% | N/A | N/A | ||
| SBEV | SPLASH BEVERAGE GROUP INC | $13.68M | $14.57M | -$19.17M | -$21.95M | -$0.49 | -27.10% | N/A | N/A | N/A | 2024-06-04 | |
| IPA | IMMUNOPRECISE ANTIBODIES LTD | $30.21M | $17.41M | -$7.05M | -$10.48M | -$0.41 | 16.75% | N/A | N/A | N/A | 2024-07-05 | |
| SGMO | SANGAMO THERAPEUTICS INC | $120.36M | $18.76M | -$314.08M | -$328.05M | -$1.86 | -92.22% | -25.16% | N/A | N/A | 2024-06-04 | |
| GRTS | GRITSTONE BIO INC | $81.43M | $15.65M | -$117.74M | -$144.89M | -$1.24 | 2.95% | 43.92% | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.